Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  3. NRXS
N

NeurAxis, Inc. (NRXS)

ASE – Real Time Price. Currency in USD

6.90

-0.10 (-1.43%)

At close: Mar 27, 2026, 4:00 PM EDT

6.95

+0.05 (0.72%)

After-hours: Mar 27, 2026, 6:49 PM EDT

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth
24.03.2026

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability.

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript
19.03.2026

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results
19.03.2026

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

CARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the fourth quarter period and full year ended December 31, 2025.

NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
17.11.2025

NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth

NeurAxis posts its fifth straight quarter of double-digit expansion, but rising costs and margin pressure weigh on third-quarter 2025 results.

NeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript
11.11.2025

NeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript

NeurAxis, Inc. ( NRXS ) Q3 2025 Earnings Call November 11, 2025 9:00 AM EST Company Participants Brian Carrico - President, CEO & Director Timothy Henrichs - Chief Financial Officer Conference Call Participants Ben Shamsian Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the NeurAxis Reports Third Quarter 2025 Financial Results Conference Call.

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
11.11.2025

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Conference call will be held today, Tuesday, November 11 at 9:00 am ET Conference call will be held today, Tuesday, November 11 at 9:00 am ET

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript
12.08.2025

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript

NeurAxis, Inc. (NYSE:NRXS ) Q2 2025 Earnings Conference Call August 12, 2025 9:00 AM ET Company Participants Brian Carrico - President, CEO & Director Timothy Robert Henrichs - Chief Financial Officer Conference Call Participants Ben Shamsian - Unidentified Company Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Lindsay Leeds - Unidentified Company Operator Good day, everyone, and welcome to the NeurAxis Report Second Quarter 2025 Financial Results. [Operator Instructions] Please note that this conference is being recorded.

Videos

No Data

There is no data to display

Press releases

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results
19.03.2026

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

CARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the fourth quarter period and full year ended December 31, 2025.

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
11.11.2025

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Conference call will be held today, Tuesday, November 11 at 9:00 am ET Conference call will be held today, Tuesday, November 11 at 9:00 am ET